EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Sex-Based Bias in Industry Payments to Medical Oncologists

Imraan Jan, Brian De, Young Suk Kwon, Robert Freeman, Kelsey Larkin, Shyamala Subramanian, Prathyusha Pandu, Amy Song, Meredith Young, Mutlay Sayan, Matthew Beier, Ethan B. Ludmir, Neha Vapiwala, Bruce G. Haffty, Malcolm D. Mattes

JCO Oncology Advances · 2025

DOI: 10.1200/oa-24-00029 ↗
AbstractBibliografische Angaben

Abstract

PURPOSE Industry payments are common among oncology researchers and can reflect professional stature and achievement; however, whether such payments differ on the basis of the sex of the recipient is unclear. METHODS To investigate potential differences in industry payments to male and female medical oncologists from 2016 through 2020, industry payment information was sourced from the Open Payments database and Centers for Medicare and Medicaid Services website. Covariate details including h-index, academic rank, institution National Institutes of Health (NIH) funding rank, sex, and practice location, were sourced from SCOPUS, Doximity, NIH RePORTER, National Plan and Provider Enumeration system, and institutional websites. Medical oncologists who received at least one industry research payment from 2016 through 2020 were included (n = 7,285). RESULTS No significant sex differences were observed in research payments; however, male medical oncologists received significantly more general payments than did female medical oncologists in several domains, including speaker fees (+194%), consulting (+204%), travel and lodging (+162%), and food and beverage (+114%). CONCLUSION Although we found no discernible sex-based differences in research funding among medical oncologists, female medical oncologists received significantly lower general payments than male medical oncologists. Efforts to improve transparency and interventions to address these discrepancies are important to ensure gender equity in oncology.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →